111In-bevacizumab imaging of renal cell cancer and evaluatio…
111In-bevacizumab imaging of renal cell cancer and evaluation of neoadjuvant treatment with the vascular endothelial growth factor receptor inhibitor sorafenib.
Article, Chapter
Full text availability for this item
Coverage:
- 1964~present; volume:5~present;issue:1~present